The HOPE4MCI study: A randomized double‐blind assessment of AGB101 for the treatment of MCI due to AD von Mohs, Richard, Bakker, Arnold, Rosenzweig‐Lipson, Sharon, Rosenblum, Michael, Barton, Russell L., Albert, Marilyn S., Cohen, Sharon, Zeger, Scott, Gallagher, Michela

Volltext

HOPE4MCI trial: First trial targeting reduction of hippocampal overactivity to treat mild cognitive impairment due to Alzheimer’s disease with AGB101 von Rosenzweig‐Lipson, Sharon, Barton, Russell, Gallagher, Michela, Mohs, Richard

Volltext

Positive Allosteric Modulation of GABAA α5 Receptors Improves Memory performance of rats with Conditions of Hippocampal Hyperactivity von Koh, Ming Teng, Rosenzweig-Lipson, Sharon, Gallagher, Michela

Volltext

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments von Balu, Darrick T, Hoshaw, Brian A, Malberg, Jessica E, Rosenzweig-Lipson, Sharon, Schechter, Lee E, Lucki, Irwin

Volltext

Anxiolytic-like activity of oxytocin in male mice : behavioral and autonomic evidence, therapeutic implications von RING, Robert H, MALBERG, Jessica E, POTESTIO, Lisa, JULIA PING, BOIKESS, Steve, BIN LUO, SCHECHTER, Lee E, RIZZO, Stacey, RAHMAN, Zia, ROSENZWEIG-LIPSON, Sharon

Volltext

Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466 von Schechter, Lee E, Lin, Qian, Smith, Deborah L, Zhang, Guoming, Shan, Qin, Platt, Brian, Brandt, Michael R, Dawson, Lee A, Cole, Derek, Bernotas, Ron, Robichaud, Albert, Rosenzweig-Lipson, Sharon, Beyer, Chad E

Volltext

The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise? von Sukoff Rizzo, Stacey J, Leonard, Sarah K, Gilbert, Adam, Dollings, Paul, Smith, Deborah L, Zhang, Mei-Yi, Di, Li, Platt, Brian J, Neal, Sarah, Dwyer, Jason M, Bender, Corey N, Zhang, Jean, Lock, Tim, Kowal, Dianne, Kramer, Angela, Randall, Andrew, Huselton, Christine, Vishwanathan, Karthick, Tse, Susanna Y, Butera, John, Ring, Robert H, Rosenzweig-Lipson, Sharon, Hughes, Zoë A, Dunlop, John

Volltext

A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia von Shen, Joan H.Q, Zhao, Yonggang, Rosenzweig-Lipson, Sharon, Popp, Danielle, Williams, Janet B.W, Giller, Earl, Detke, Michael J, Kane, John M

Volltext

Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist von Ring, Robert H., Schechter, Lee E., Leonard, Sarah K., Dwyer, Jason M., Platt, Brian J., Graf, Radka, Grauer, Steven, Pulicicchio, Claudine, Resnick, Lynn, Rahman, Zia, Sukoff Rizzo, Stacey J., Luo, Bin, Beyer, Chad E., Logue, Sheree F., Marquis, Karen L., Hughes, Zoë A., Rosenzweig-Lipson, Sharon

Volltext

Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects von Malberg, Jessica E, Platt, Brian, Rizzo, Stacey J Sukoff, Ring, Robert H, Lucki, Irwin, Schechter, Lee E, Rosenzweig-Lipson, Sharon

Volltext

Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist von Dunlop, John, Watts, Stephanie W, Barrett, James E, Coupet, Joseph, Harrison, Boyd, Mazandarani, Hossein, Nawoschik, Stanley, Pangalos, Menelas N, Ramamoorthy, Siva, Schechter, Lee, Smith, Deborah, Stack, Gary, Zhang, Jean, Zhang, Guoming, Rosenzweig-Lipson, Sharon

Volltext

The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders? von Logue, Sheree F., Grauer, Steven M., Paulsen, Janet, Graf, Radka, Taylor, Noel, Sung, M. Amy, Zhang, Lynn, Hughes, Zoë, Pulito, Virginia L., Liu, Feng, Rosenzweig-Lipson, Sharon, Brandon, Nicholas J., Marquis, Karen L., Bates, Brian, Pausch, Mark

Volltext

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503 von Rosenzweig-Lipson, Sharon, Zhang, Jean, Mazandarani, Hossein, Harrison, Boyd L, Sabb, Annmarie, Sabalski, Joan, Stack, Gary, Welmaker, Greg, Barrett, James E, Dunlop, John

Volltext

Opportunities for Cellular Rejuvenation in Alzheimer’s Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches von Rosenzweig-Lipson, Sharon

Volltext

A novel approach for predicting antidepressant-induced sexual dysfunction in rats von Sukoff Rizzo, Stacey J., Schechter, Lee E., Rosenzweig-Lipson, Sharon

Volltext

Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse von Balu, Darrick T., Hodes, Georgia E., Hill, Tiffany E., Ho, Nancy, Rahman, Zia, Bender, Corey N., Ring, Robert H., Dwyer, Jason M., Rosenzweig-Lipson, Sharon, Hughes, Zoe A., Schechter, Lee E., Lucki, Irwin

Volltext

Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective α2A-adrenoceptor antagonism von Dwyer, Jason M., Platt, Brian J., Sukoff Rizzo, Stacey J., Pulicicchio, Claudine M., Wantuch, Caitlin, Zhang, Mei-Yi, Cummons, Terri, Leventhal, Liza, Bender, Corey N., Zhang, Jean, Kowal, Dianne, Lu, Shendi, Rajarao, S. Johannes R., Smith, Deborah L., Shilling, Adam D., Wang, Jianyao, Butera, John, Resnick, Lynn, Rosenzweig-Lipson, Sharon, Schechter, Lee E., Beyer, Chad E.

Volltext

Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon von Rajarao, S. Johannes R, Platt, Brian, Sukoff, Stacey J, Lin, Qian, Bender, Corey N, Nieuwenhuijsen, Bart W, Ring, Robert H, Schechter, Lee E, Rosenzweig-Lipson, Sharon, Beyer, Chad E

Volltext

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antips... von Brennan, Julie A, Graf, Radka, Grauer, Steven M, Navarra, Rachel L, Pulicicchio, Claudine M, Hughes, Zoë A, Lin, Qian, Wantuch, Caitlin, Rosenzweig-Lipson, Sharon, Pruthi, Farhana, Lai, Margaret, Smith, Deborah, Goutier, Wouter, van de Neut, Martina, Robichaud, Albert J, Rotella, David, Feenstra, Rolf W, Kruse, Chris, Broqua, Pierre, Beyer, Chad E, McCreary, Andrew C, Pausch, Mark H, Marquis, Karen L

Volltext

Structure−Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors von Mahaney, Paige E, Gavrin, Lori K, Trybulski, Eugene J, Stack, Gary P, Vu, An T, Cohn, Stephen T, Ye, Fei, Belardi, Justin K, Santilli, Arthur A, Sabatucci, Joseph P, Leiter, Jennifer, Johnston, Grace H, Bray, Jenifer A, Burroughs, Kevin D, Cosmi, Scott A, Leventhal, Liza, Koury, Elizabeth J, Zhang, Yingru, Mugford, Cheryl A, Ho, Douglas M, Rosenzweig-Lipson, Sharon J, Platt, Brian, Smith, Valerie A, Deecher, Darlene C

Volltext